Personalized exercise prescriptions aim to keep frail seniors on their feet

NCT ID NCT07787663

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This study tests whether a tool called PACE can help doctors prescribe specific, tailored physical activity programs for frail older adults. The goal is to prevent declines in physical function and independence. Participants will follow a daily exercise plan for 12 weeks, and researchers will measure how feasible and acceptable the program is in a real-world clinic setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tailored physical activity programs (PACE tool) with 35 exercise plans and walking goals, prescribed daily for 12 weeks.
What this could lead to
If successful, this could provide a practical way for doctors to prescribe personalized exercise that helps frail older adults maintain independence and reduce caregiver burden.
What could go wrong
This is a feasibility study, so it focuses on whether the program can be implemented, not on proving health benefits. Results may not show significant physical improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

162 people

The number who actually took part.

Started

Mar 2021

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * being followed in an outpatient geriatric clinic * Aged 60 years and older, with or without an informal caregiver * Have the cognitive capacity to provide informed consent; * Have no contraindications to physical activity; * Are not currently receiving rehabilitation services; * Are able to communicate, read, and understand French or English; Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Frailty are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UQAM

    Montreal, Quebec, H3P 3C8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.